WOLFS PHARMA
ActiveSummary
WOLFS PHARMA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €40,540 and a net result of €30,540. Its solvency ranks better than 28% of 22,080 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.9% (low).